Cullinan Therapeutics, Inc. (CGEM)

Healthcare · Biotechnology · NASDAQ

Cullinan Therapeutics, Inc. (CGEM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.09B and a free-cash-flow yield of -16.8%.

Market cap	$1.09B
Trailing P/E	—
FCF yield	-16.8%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CGEM data on Nama Insights →